Abstract: Disclosed herein are system, method, and computer program product embodiments for facilitating access to and incorporation of APIs within an application during development, while ensuring that the API satisfies quality constraints. These quality constraints are controlled by the application of rules, which result in a maturity score for the API, in accordance with embodiments. These rules may be provided by a variety of sources for use in scoring the API at various stages. For example, a developer group may control access to developers within the group by applying a ruleset that restricts APIs for applications written by the developer group to a threshold score. This threshold score can limit or restrict APIs that are offered to a developer by an API exchange. Additionally, a ruleset may be applied to enforce a minimum score for submission of an API for inclusion within an API exchange.

Abstract: Disclosed herein are system, method, and computer program product embodiments for facilitating access to and incorporation of APIs within an application during development, while ensuring that the API satisfies quality constraints. These quality constraints are controlled by the application of rules, which result in a maturity score for the API, in accordance with embodiments. These rules may be provided by a variety of sources for use in scoring the API at various stages. For example, a developer group may control access to developers within the group by applying a ruleset that restricts APIs for applications written by the developer group to a threshold score. This threshold score can limit or restrict APIs that are offered to a developer by an API exchange. Additionally, a ruleset may be applied to enforce a minimum score for submission of an API for inclusion within an API exchange.

Abstract: This disclosure relates to a mechanism to create conversational agents from API specifications based on domain-specific inputs. The conversational agents may provide the functionalities exposed by the underlying API to users engaging with the conversational agent. Thus, the user may execute actions exposed by the API specification using natural language in a conversational, comfortable, and familiar fashion.

Abstract: A plurality of network application programming interfaces (APIs) are received. The plurality of network APIs are transformed then mapped into a unified data graph. A query in a distributed computing environment is performed using the unified data graph or performing discovery for at least one of the plurality of network APIs using the unified data graph.

Abstract: A plurality of network APIs are received. The plurality of network APIs are transformed then mapped into a unified data graph. A query in a distributed computing environment is performed using the unified data graph or performing discovery for at least one of the plurality of network APIs using the unified data graph.

Abstract: This disclosure relates to a mechanism to create conversational agents from API specifications based on domain-specific inputs. The conversational agents may provide the functionalities exposed by the underlying API to users engaging with the conversational agent. Thus, the user may execute actions exposed by the API specification using natural language in a conversational, comfortable, and familiar fashion.

Abstract: The invention relates to an immunogenic peptide of eight amino acids that is generated naturally in the intestine of celiac patients by means of the hydrolysis of ingested gluten. In addition, the invention relates to the use of the peptide, or antibodies generated against same, for the in vitro monitoring and/or diagnosis of celiac disease, as well as to the use of such antibodies for the detection of gluten in food. The invention further relates to the use of the aforementioned peptide as a therapeutic target for the development of compounds or compositions for use in the diagnosis, treatment and/or prevention of this pathological condition, as well as to the use of the peptide and the antibodies against same for the prevention and/or treatment of celiac disease.